Advertisement

New Insight: Phase 2 BEHOLD Study and UBX1325 for DME, Live at AAO 2023

Published on: 

On the floor at AAO 2023, host Veeral Sheth, MD, discusses UBX1325 for patients with diabetic macular edema, based on the 48-week results from the phase 2 BEHOLD study.

On the floor at AAO 2023, host Veeral Sheth, MD, and producer Connor Iapoce discuss UBX1325 for patients with diabetic macular edema (DME), based on the 48-week results from the phase 2 BEHOLD study.

Every episode of New Insight is available on HCPLive.com and be sure to subscribe to our channel on Spotify, Apple Podcasts, and YouTube. Please direct any podcast-related inquiries to show producer Connor Iapoce at ciapoce@mjhlifesciences.com.

Keep an eye out for more from New Insight!


Advertisement
Advertisement